Scan to Download
One power score. Smarter investment decisions
Beta Bionics Inc
BBNX23.050USD
-0.060-0.26%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
23.050USD+23.050After-hours 09/18, 20:00 (ET)
1.00BMarket Cap
LossP/E TTM
Beta Bionics Inc
23.050
-0.060-0.26%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2023Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---13.59M
---19.98M
-124.97%-14.28M
---6.35M
Net income from continuing operations
---16.87M
---28.66M
3.93%-18.11M
---18.85M
Operating gains losses
--653.00K
--604.00K
-2.76%529.00K
--544.00K
Other non-cash items
---678.00K
---705.00K
-41.98%-1.04M
---736.00K
Change in working capital
---1.50M
---6.47M
-472.97%-3.24M
---566.00K
-Change in receivables
---2.33M
--2.94M
-84.01%-4.56M
---2.48M
-Change in inventory
---1.73M
---2.62M
-72.16%-1.58M
---916.00K
-Change in prepaid expenses
---1.98M
---1.62M
-308.70%-1.13M
---276.00K
-Change in other current assets
--2.00K
--4.00K
103.45%1.00K
---29.00K
-Change in other current liabilities
--1.54M
--480.00K
228.99%783.00K
--238.00K
Cash from non-recurring investing activities
Cash from operating activities
---13.59M
---19.98M
-124.97%-14.28M
---6.35M
Investing cash flow
Net cash from continuing investing activities
--1.78M
--333.00K
79.23%561.00K
--313.00K
Capital expenditures
--1.78M
--333.00K
79.23%561.00K
--313.00K
Net cash flow from disposal of fixed assets
--1.78M
--333.00K
79.23%561.00K
--313.00K
Net cash flow from investment products
--7.95M
---178.79M
58.00%-29.10M
---69.30M
Net cash flow from other investing activities
----
----
--0.00
----
Cash from non-current investing activities
Net cash flow from investing activities
--6.17M
---179.12M
57.39%-29.66M
---69.61M
Financing cash flow
Cash flow from continuous financing activities
--42.00K
--211.12M
632033.33%56.89M
--9.00K
Net cash flow from common stock issuance/repurchase
--0.00
--211.02M
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
--59.66M
--0.00
Proceeds from stock option exercised by employees
--42.00K
--98.00K
311.11%37.00K
--9.00K
Proceeds from issuance of warrants
----
----
--1.00K
--0.00
Net cash flow from other financing activities
----
----
---2.81M
----
Net cash from non-recurrent financing activities
Net cash from financing activities
--42.00K
--211.12M
632033.33%56.89M
--9.00K
Net cash flow
Beginning cash balance
--42.55M
--30.53M
-82.87%17.58M
--102.61M
Current period cash flow changes
---7.38M
--12.02M
117.05%12.95M
---75.95M
Ending cash balance
--35.17M
--42.55M
14.50%30.53M
--26.67M
Free cash flow
---15.37M
---20.31M
-122.82%-14.84M
---6.66M
Currency unit
USD
USD
USD
USD
Audit opinions
--
--
--
--
